LEXX
Lexaria Bioscience Corp.
NASDAQ · Healthcare · Biotechnology · CA
$14.15
+14.85%Margins
Gross margin
100.0%
EBITDA margin
-3958.1%
EBIT margin
-3973.2%
Net margin
-3985.6%
FCF margin
-3880.1%
-163.2%
Return on equity
-161.7%
Return on assets
-159.8%
Return on invested capital
0.03x
Asset turnover
-$7.4M
Cash from operations
$2.19
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of May 1, 2026